Robert A. Doti
Eli Lilly (United States)(US)
Publications by Year
Research Areas
Estrogen and related hormone effects, Inflammatory mediators and NSAID effects, Asthma and respiratory diseases, Thyroid Disorders and Treatments, Protease and Inhibitor Mechanisms
Most-Cited Works
- → Discovery of Potent, Selective, and Orally Active Carboxylic Acid Based Inhibitors of Matrix Metalloproteinase-13(2009)56 cited
- → 3,3-Bisaryloxindoles as mineralocorticoid receptor antagonists(2005)53 cited
- → Identification of potent and selective retinoic acid receptor gamma (RARγ) antagonists for the treatment of osteoarthritis pain using structure based drug design(2016)22 cited
- → Carboxy-Substituted Cinnamides: A Novel Series of Potent, Orally Active LTB4 Receptor Antagonists(1998)20 cited
- → Simultaneous determination of enantiomeric purity and erythro/threo relationship in chiral 1,2-aminoalcohols by NMR using (R)-(+)-t-butylphenylphosphinothioic acid(1999)18 cited
- → Design and synthesis of a novel series of [1-(4-hydroxy-benzyl)-1H-indol-5-yloxy]-acetic acid compounds as potent, selective, thyroid hormone receptor β agonists(2015)9 cited
- → N-aryl cinnamides: A novel class of rigid and highly potent leukotriene B4 receptor antagonists(1997)7 cited
- → ChemInform Abstract: N‐Aryl Cinnamides: A Novel Class of Rigid and Highly Potent Leukotriene B4 Receptor Antagonists.(1997)